These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34521861)

  • 1. Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition.
    Dean B; Scarr E
    NPJ Schizophr; 2021 Sep; 7(1):44. PubMed ID: 34521861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.
    Scarr E; Craig JM; Cairns MJ; Seo MS; Galati JC; Beveridge NJ; Gibbons A; Juzva S; Weinrich B; Parkinson-Bates M; Carroll AP; Saffery R; Dean B
    Transl Psychiatry; 2013 Feb; 3(2):e230. PubMed ID: 23423139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of cholinergic receptor muscarinic 1 impairs cortical mitochondrial structure and function: implications in Alzheimer's disease.
    Sabbir MG; Swanson M; Albensi BC
    Front Cell Dev Biol; 2023; 11():1158604. PubMed ID: 37274741
    [No Abstract]   [Full Text] [Related]  

  • 4. Hippocampal versus cortical deletion of cholinergic receptor muscarinic 1 in mice differentially affects post-translational modifications and supramolecular assembly of respiratory chain-associated proteins, mitochondrial ultrastructure, and respiration: implications in Alzheimer's disease.
    Sabbir MG; Swanson M; Speth RC; Albensi BC
    Front Cell Dev Biol; 2023; 11():1179252. PubMed ID: 37293125
    [No Abstract]   [Full Text] [Related]  

  • 5. COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex.
    Dean B; Scarr E
    Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):784-9. PubMed ID: 26954460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
    Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
    Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower levels of soluble β-amyloid precursor protein, but not β-amyloid, in the frontal cortex in schizophrenia.
    Dean B; Duce J; Li QX; Masters CL; Scarr E
    Psychiatry Res; 2024 Jan; 331():115656. PubMed ID: 38071879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression.
    Scarr E; Sundram S; Deljo A; Cowie TF; Gibbons AS; Juzva S; Mackinnon A; Wood SJ; Testa R; Pantelis C; Dean B
    Schizophr Res; 2012 Jun; 138(1):94-8. PubMed ID: 22391213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
    Liao DL; Hong CJ; Chen HM; Chen YE; Lee SM; Chang CY; Chen H; Tsai SJ
    Neuropsychobiology; 2003; 48(2):72-6. PubMed ID: 14504414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.
    Dean B; Hopper S; Conn PJ; Scarr E
    Neuropsychopharmacology; 2016 May; 41(6):1620-8. PubMed ID: 26511338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower levels of cortical [
    Dean B; Haroutunian V; Scarr E
    Schizophr Res; 2023 May; 255():274-282. PubMed ID: 37079947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic Receptor Muscarinic 1 Co-Localized with Mitochondria in Cultured Dorsal Root Ganglion Neurons, and Its Deletion Disrupted Mitochondrial Ultrastructure in Peripheral Neurons: Implications in Alzheimer's Disease.
    Sabbir MG
    J Alzheimers Dis; 2024; 98(1):247-264. PubMed ID: 38427478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B
    J Psychiatry Neurosci; 2018 Aug; 43(5):338-346. PubMed ID: 30125244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex, Age, and Regional Differences in
    Sanfilippo C; Giuliano L; Castrogiovanni P; Imbesi R; Ulivieri M; Fazio F; Blennow K; Zetterberg H; Di Rosa M
    Curr Neuropharmacol; 2023; 21(3):740-760. PubMed ID: 36475335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher levels of AKT-interacting protein in the frontal pole from people with schizophrenia are limited to a sub-group who have a marked deficit in cortical muscarinic M1 receptors.
    Snelleksz M; Dean B
    Psychiatry Res; 2024 Nov; 341():116156. PubMed ID: 39236366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    Scarr E; Hopper S; Vos V; Seo MS; Everall IP; Aumann TD; Chana G; Dean B
    J Psychiatry Neurosci; 2018 May; 43(4):170202. PubMed ID: 29848411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
    Seo MS; Scarr E; Dean B
    Schizophr Res; 2014 Sep; 158(1-3):247-54. PubMed ID: 25037527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
    Scarr E; Cowie TF; Kanellakis S; Sundram S; Pantelis C; Dean B
    Mol Psychiatry; 2009 Nov; 14(11):1017-23. PubMed ID: 18317461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B; Soulby A; Evin GM; Scarr E
    Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.
    Hopper S; Pavey GM; Gogos A; Dean B
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):640-650. PubMed ID: 31428788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.